Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s) [PDF]
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Thrombocytopenia is a rare but serious complication of the intravenous glycoprotein IIb/IIIa (GPIIb/IIIa; integrin αIIbβ3) receptor inhibitors (GPIs), abciximab, eptifibatide, and tirofiban. The thrombocytopenia ranges from mild (50 000–100 000 platelets/
Sem A. O. F. Rikken +4 more
doaj +2 more sources
Heparin and Bivalirudin in Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Review Article. [PDF]
Cardiovasc TherAcute coronary syndrome (ACS) is one of the most common leading global causes of mortality, encompassing ST‐segment elevation myocardial infarction (STEMI), non‐ST‐segment elevation myocardial infarction (NSTEMI), and unstable angina (UA). Percutaneous coronary intervention (PCI) has become a pivotal therapeutic approach for ACS, underscoring the ...
Wang G +8 more
europepmc +2 more sources
Evaluate Short-Term Outcomes of abciximab in ST-Segment Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Clinical Trials [PDF]
Journal of Interventional Cardiology, 2022 Objectives. This meta-analysis was to verify the short-time efficacy and safety of abciximab in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI). Background.
Nan Bai +5 more
doaj +2 more sources
The use of abciximab associated with primary angioplasty for treating acute myocardial infarction [PDF]
Arquivos Brasileiros de Cardiologia, 2002 OBJECTIVE: To assess the benefit resulting from the use of abciximab associated with primary angioplasty. The following parameters were analyzed in-hospital, at 30 days, and 6 months: (a) flow in the culprit artery; (b) ventricular function; (c) combined
Manuel Lisandro Hernández Brito +6 more
doaj +2 more sources
Self-Reporting Theranostic: Nano Tool for Arterial Thrombosis [PDF]
Bioengineering, 2023 Arterial thrombosis (AT) originates through platelet-mediated thrombus formation in the blood vessel and can lead to heart attack, stroke, and peripheral vascular diseases.
Suryyani Deb +6 more
doaj +2 more sources
Efficacy and safety of abciximab in diabetic patients who underwent percutaneous coronary intervention with thienopyridines loading: a meta-analysis. [PDF]
PLoS ONE, 2011 BACKGROUND: It has been controversial whether abciximab offered additional benefits for diabetic patients who underwent percutaneous coronary intervention (PCI) with thienopyridines loading.
Yihua Wu +6 more
doaj +1 more source
Intracoronary versus intravenous administration of abciximab in patients with acute coronary syndrome: a meta-analysis. [PDF]
PLoS ONE, 2013 BACKGROUND: Abciximab is a widely used adjunctive therapy for acute coronary syndrome (ACS). However, the effect of intracoronary (i.c.) administration of abciximab on cardiovascular events remains unclear when compared with intravenous (i.v.) therapy ...
Jie-Ning Wang +6 more
doaj +1 more source
Brain Circulation, 2021 Cerebral ischemia following clipping of cerebral aneurysms constitutes major cause of morbidity and mortality. Clip-related injury to vessel, postoperative clip rotation, prolonged temporary occlusion, intraoperative rupture, and vasospasm are some ...
Chirag Jain +3 more
doaj +1 more source
Platelets, 2022 Immediate reocclusion after mechanical thrombectomy (MT) for acute ischemic stroke (AIS) is a rare but devastating condition associated with poor functional outcome.
François Delvoye +19 more
doaj +1 more source
Alveolar Hemorrhage during Abciximab Infusion
Journal of Tehran University Heart Center, 2021 Not ...
Yavuzer Koza +3 more
doaj +1 more source